ArticleBiomolecules2026
Integrative Multi-Analysis Identifies METTL3-Regulated FGF19 and H6PD as Candidate Targets in Diabetic Cognitive Impairment.
Jun Fu, Huarui Wang, Junjie Yan, Weiyuan Chen, Ruguang Wang, Hongchang Gao, Chen Li
Abstract read
In one paragraphArticle in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Jun FuState Key Laboratory of Macromolecular Drugs and Large-Scale Manufacturing, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.
Huarui WangState Key Laboratory of Macromolecular Drugs and Large-Scale Manufacturing, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.
Junjie YanState Key Laboratory of Macromolecular Drugs and Large-Scale Manufacturing, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.
Weiyuan ChenState Key Laboratory of Macromolecular Drugs and Large-Scale Manufacturing, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.
Ruguang WangState Key Laboratory of Macromolecular Drugs and Large-Scale Manufacturing, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.
Hongchang GaoState Key Laboratory of Macromolecular Drugs and Large-Scale Manufacturing, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.
Chen LiState Key Laboratory of Macromolecular Drugs and Large-Scale Manufacturing, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.
Funding
Zhejiang Provincial Natural Science Foundation of China LMS25H310004
6 · The paper itselfAbstract
Diabetic cognitive impairment (DCI) is a serious and growing public health concern. The role of N6-methyladenosine (m
Indexed as
Cognitive DysfunctionFibroblast Growth FactorsMethyltransferasesMonosaccharide Transport ProteinsAdenosineAnimalsEpitranscriptomeHumansMembrane GlycoproteinsMiceNerve Tissue ProteinsRNA MethylationAdenosineFibroblast Growth FactorsGpm6a protein, mouseMembrane GlycoproteinsMethyltransferasesMETTL3 protein, humanMettl3 protein, mouseMonosaccharide Transport ProteinsNerve Tissue ProteinsN-methyladenosine1H-NMR metabolomicsdiabetic cognitive impairmentm6A methylationMETTL3
Identifiers
PMID41897403
PMCPMC13023568
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390